Literatura académica sobre el tema "Optimisation de hit en lead"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Optimisation de hit en lead".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Optimisation de hit en lead"
Padalino, Gilda, Nelly El-Sakkary, Lawrence J. Liu, Chenxi Liu, Danielle S. G. Harte, Rachel E. Barnes, Edward Sayers et al. "Anti-schistosomal activities of quinoxaline-containing compounds: From hit identification to lead optimisation". European Journal of Medicinal Chemistry 226 (diciembre de 2021): 113823. http://dx.doi.org/10.1016/j.ejmech.2021.113823.
Texto completoEl Bakali, Jamal, Lucie Maingot, Julie Dumont, Helene Host, Akila Hocine, Nicolas Cousaert, Sandrine Dassonneville, Florence Leroux, Benoit Deprez y Rebecca Deprez-Poulain. "Novel selective inhibitors of neutral endopeptidase: discovery by screening and hit-to-lead optimisation". MedChemComm 3, n.º 4 (2012): 469. http://dx.doi.org/10.1039/c2md00287f.
Texto completoBobrovs, Raitis, Jekaterina Bolsakova, Jhon Alexander Rodriguez Buitrago, Larisa Varaceva, Marija Skvorcova, Iveta Kanepe, Anastasija Rudnickiha, Emilio Parisini y Aigars Jirgensons. "Structure-based identification of salicylic acid derivatives as malarial threonyl tRNA-synthetase inhibitors". PLOS ONE 19, n.º 4 (1 de abril de 2024): e0296995. http://dx.doi.org/10.1371/journal.pone.0296995.
Texto completoMostarda, Serena, Tugçe Gür Maz, Alessandro Piccinno, Bruno Cerra y Erden Banoglu. "Optimisation by Design of Experiment of Benzimidazol-2-One Synthesis under Flow Conditions". Molecules 24, n.º 13 (3 de julio de 2019): 2447. http://dx.doi.org/10.3390/molecules24132447.
Texto completoOsborne, James, Stanislava Panova, Magdalini Rapti, Tatsuya Urushima y Harren Jhoti. "Fragments: where are we now?" Biochemical Society Transactions 48, n.º 1 (27 de enero de 2020): 271–80. http://dx.doi.org/10.1042/bst20190694.
Texto completoTaki, Aya C., Joseph J. Byrne, Tao Wang, Brad E. Sleebs, Nghi Nguyen, Ross S. Hall, Pasi K. Korhonen et al. "High-Throughput Phenotypic Assay to Screen for Anthelmintic Activity on Haemonchus contortus". Pharmaceuticals 14, n.º 7 (26 de junio de 2021): 616. http://dx.doi.org/10.3390/ph14070616.
Texto completoZaidi, Norburhanuddin Johari, Adib Afandi Abdullah, Choon Han Heh, Chun-Hung Lin, Rozana Othman y Abdullah Al Hadi Ahmad Fuaad. "Hit-to-Lead Short Peptides against Dengue Type 2 Envelope Protein: Computational and Experimental Investigations". Molecules 27, n.º 10 (18 de mayo de 2022): 3233. http://dx.doi.org/10.3390/molecules27103233.
Texto completoKandil, Sahar B., Samuel R. Jones, Sonia Smith, Stephen E. Hiscox y Andrew D. Westwell. "Structure-Based Virtual Screening, Synthesis and Biological Evaluation of Potential FAK-FAT Domain Inhibitors for Treatment of Metastatic Cancer". Molecules 25, n.º 15 (31 de julio de 2020): 3488. http://dx.doi.org/10.3390/molecules25153488.
Texto completoScanlon, Martin. "Monash Fragment Platform". Impact 2018, n.º 3 (15 de junio de 2018): 32–34. http://dx.doi.org/10.21820/23987073.2018.3.32.
Texto completoMager, Magnus. "Noise performance of the ALPIDE-based ALICE Inner Tracking System". Journal of Physics: Conference Series 2374, n.º 1 (1 de noviembre de 2022): 012062. http://dx.doi.org/10.1088/1742-6596/2374/1/012062.
Texto completoTesis sobre el tema "Optimisation de hit en lead"
Quevedo, Camilo E. "Design and synthesis of Quinazolinone-based libraries for inhibitation of Kinase activity and hit-to-lead optimisation of Wnt pathway inhibitors". Thesis, Institute of Cancer Research (University Of London), 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.510367.
Texto completoBorzakian, Sibyline. "Identification et développement chimique d'inducteurs de protéines immunorégulatrices (SLPI et IL-10) à visée thérapeutique". Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASF012.
Texto completoThe work carried out during this thesis has been divided into three distincts parts, all relating to the developpement of compounds for therapeutic use. The first part of this manuscript is devoted to the identification of inducers of Secretory Leucocyte Protease Inhibitor (SLPI), a protein mainly produced by immune and epithelial cells, with numerous promising biological properties. A phenotypic screening was conducted using two academic chemical libraries, leading to the identification of 5 hits able of inducing SLPI production by B cells. This work paved the way for potential therapeutic applications of these compounds, particularly in the development of antibiotic or anti-inflammatory treatments. The second part of this manuscript is dedicated to identifying a pharmacophore for inducers of Interleukin-10 (IL-10), a cytokine produced by immune cells, whose main role is the regulation of immunity. Prior to this thesis, a phenotypic screening was conducted to identifiy inducers of IL-10 production by B cells for use in cell therapy to reduce symptoms of multiple sclerosis. This thesis work involved hit-to-lead optimization of the most promising compound to identify a pharmacophore for IL-10 inducers through the establishment of robust structure-activity relationships. During this phase, 240 analogs were synthetized. Finally, the third part of this manuscript focuses on the development of a photochemical synthesis methology for accessing original heterocylic compounds. This methology, requiring neither heating nor metallic catalysts, aligns with the development of greener chemistry
Samson, Samantha. "Profilage in silico de la protéine multifonctionnelle Mfd, une cible thérapeutique innovante dans la lutte contre l'antibiorésistance bactérienne". Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASL125.
Texto completoIn an alarming context of antibiotic resistance, the search for new antimicrobials is an urgent health issue. We had identified the bacterial protein Mutation Frequency Decline (Mfd) as an innovative target for the development of new drugs. A high throughput in silico screening was initially performed in order to select molecules specifically binding to the active site of the target and inhibiting its activity, thereby preventing bacterial resistance to host immune stress. The identified hits were shown to be efficient in vitro and efficient and non-toxic in vivo, in an insect model of infection on at least two bacterial pathogens. These preliminary data have constituted a proof of concept of the innovative potential of these hits and were also the basis of this thesis.The main objective of this work was the identification of the critical molecular interaction found between those hits and the active site of Mfd in E. coli and also enlarged to the priority pathogens of the ESKAPE group. As a result, an optimal inhibitor scaffold was determined and its derivatives are currently tested in vitro and in vivo as potential antimicrobial agents. In parallel, the sequence and structure analysis of Mfd, from environmental and clinical strains, showcase the basic features of a molecular correlation between Mfd sequence and virulence phenotype. The in vitro confirmation is currently being evaluated. Finally, my goal reposition this motor function of Mfd into a larger conformational and functional remodeling of Mfd in order to get a better understanding of this target and its role in the Nucleotide Excision Repair. Using molecular dynamics simulation on distinguished linkers that connect the main functional modules of Mfd, the investigation of their intrinsic flexibility and resilience to recapitulate the extensive remodeling of Mfd conformations within its functional cycle that has been previously described by cryo-EM. This aims to document to which extent the linkers that connect this multi-module protein are more than "linkers" and harbor, in their sequence and length, internal properties to adopt discrete states that guarantee disorder-to-coil transition to assure the functional machinery of Mfd
Papadatos, George. "Data mining for lead optimisation". Thesis, University of Sheffield, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.556989.
Texto completoNeiström, Linda. "Characterisation of Used Lead-Acid Batteries for Feed Optimisation in Secondary Lead Production". Thesis, Luleå tekniska universitet, Institutionen för samhällsbyggnad och naturresurser, 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-70740.
Texto completoYglesias, Tatiana. "Application of process analysis and optimization tools in hit-to-lead and lead optimization phases of drug discovery at EPP, NIBR". Thesis, Massachusetts Institute of Technology, 2010. http://hdl.handle.net/1721.1/59882.
Texto completoCataloged from PDF version of thesis.
Includes bibliographical references (p. 82-84).
Given that research is based on innovation, it has been believed that its activities can only be optimized with equipment upgrade, increment in personnel scientific knowledge, development of new analytical software and/or changing the areas of study. After realizing the limited results achieved with these approaches, lab representatives started to notice the opportunity of introducing process optimization tools, such as Lean and Six Sigma, which showed success in manufacturing environments,. This project analyzes the interrelation between process and results, providing a clear explanation of cause and effect conditions, and a concise list of areas for improvement. Specifically, the document defines a measurement system using process maps and key performance indicators (KPIs). With this, the document describes the current state through historic trends, provides a complete data and root cause analysis for current state description, and provides a process capability study for the available indicators. Implementation of the steps mentioned above show how focus in lab turnaround times have been deviating attention from more impactful improvements, which can greatly affect overall drug discovery duration. Also, the analysis identifies that constant technology changes caused constant adaptation of process procedures, which generated non-value added activities. These non-value added activities today occupy about 50% of a lab associate's time. Lastly, historic data evaluation shows that root cause statistical analysis is limited by the presence of a combination of special and common cause variations. Some of the project recommendations include: incorporation of chemist's knowledge about compound potency, integration of equipment and software information, change in booking system, incorporation of assay and plate criteria, definition of standard procedures for specific activities, and integration of assay development and data submission tools. Overall, these changes can lead to a 50% reduction in the profiling times greater than 60 days, decrease of 62% and 60% in Compound Manager (CM) and Compound Profiler (CP) non-value added times respectively, 30% decrease in CM and CP total duration per assay plate, and increase in profiling time stability and predictability. Despite the fact that timing and scale of available resources will impact the realized benefits, the proposed framework gives EPP the opportunity to assess the improvements by their effect and alignment with goals.
by Tatiana Yglesias.
M.B.A.
S.M.
Voitovich, Iuliia. "Les inhibiteurs d'interaction protéine-protéine, une stratégie innovante en cancérologie". Thesis, Aix-Marseille, 2018. http://www.theses.fr/2018AIXM0701.
Texto completoBET-proteins, acting as epigenetic readers, play an essential role in cancer development. To date, numerous potent inhibitors disrupting BET functions have been discovered, including several of them that are undergoing clinical trials for the treatment of different types of cancer. The common drawback limiting their use in clinical practice is an inability to distinguish between BET-members that may cause side effects and resistances. The selective targeting of individual BET and the discrimination between BD1 and BD2 present an opportunity to achieve more selective transcriptional effect. A midthroughput screening of previously designed chemical library allowed identification of two molecules with unique profiles of selectivity that have never been observed. An undertaken structure-based program revealed a minimum scaffolds necessary for binding. Taking together with resolved X-Ray structures it allowed the development of more potent and selective BET inhibitors by DOTS (diversity oriented target focused synthesis) strategy, combining virtual screening and diversity oriented library design. This optimization led to a potent inhibitor with up to 100-fold improvement of affinity to the target and up to 300-fold selectivity toward BD1. Dose-response downregulation of c-Myc levels in low micromolar range in cell assays allowed the validation of the identified molecule as a chemical probe. Further comprehensive in vitro and in vivo evaluations of this compound will enable elucidating the biological role of each bromodomain and a validation of the interest toward the development of selective inhibitors in clinic
Mariani, Alessandro. "Optimisation of valve regulated lead acid battery design for high power applications". Thesis, University of South Wales, 2017. https://pure.southwales.ac.uk/en/studentthesis/optimisation-of-valve-regulated-lead-acid-battery-design-for-high-power-applications(f8316110-ebc1-4f0b-9e1b-4a66d7e50564).html.
Texto completoFilippi, Andrea <1990>. "An application of Genetic Algorithms for the Lead Molecule Optimisation. (Titolo provvisorio)". Master's Degree Thesis, Università Ca' Foscari Venezia, 2016. http://hdl.handle.net/10579/9366.
Texto completoMoffat, Kirstin. "Development of computational methods for 3D similarity and structure-based design techniques in lead optimisation". Thesis, University of Sheffield, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.434521.
Texto completoLibros sobre el tema "Optimisation de hit en lead"
Faller, Bernard y Laszlo Urban, eds. Hit and Lead Profiling. Wiley, 2009. http://dx.doi.org/10.1002/9783527627448.
Texto completoRamaswamy, Vijayan y Vasanthanathan Poongavanam. Computational Drug Discovery: From Hit to Lead Optimization. Wiley & Sons, Limited, John, 2023.
Buscar texto completoOptimisation of Corrosion Control for Lead in Drinking Water Using Computational Modelling Techniques. IWA Publishing, 2013.
Buscar texto completoHayes, Colin, Croft, T N. Optimisation of Corrosion Control for Lead in Drinking Water Using Computational Modelling Techniques. IWA Publishing, 2012.
Buscar texto completoUrban, Laszlo, Gerd Folkers, Raimund Mannhold, Hugo Kubinyi y Bernard Faller. Hit and Lead Profiling: Identification and Optimization of Drug-Like Molecules. Wiley & Sons, Limited, John, 2010.
Buscar texto completoUrban, Laszlo, Gerd Folkers, Raimund Mannhold, Hugo Kubinyi y Bernard Faller. Hit and Lead Profiling: Identification and Optimization of Drug-Like Molecules. Wiley & Sons, Limited, John, 2010.
Buscar texto completoUrban, Laszlo, Gerd Folkers, Raimund Mannhold, Hugo Kubinyi y Bernard Faller. Hit and Lead Profiling: Identification and Optimization of Drug-Like Molecules. Wiley & Sons, Limited, John, 2010.
Buscar texto completoHit and lead profiling: Identification and optimization of drug-like molecules. Weinheim: Wiley-VCH, 2009.
Buscar texto completoUrban, Laszlo, Gerd Folkers, Raimund Mannhold, Hugo Kubinyi y Bernard Faller. Hit and Lead Profiling: Identification and Optimization of Drug-Like Molecules. Wiley & Sons, Incorporated, John, 2009.
Buscar texto completoNow Lead the Change: Repurpose Your Career, Future-Proof Your Organization, and Regenerate Our Crisis-Hit World by Mastering Transformational Leadership. Switch On Books, 2020.
Buscar texto completoCapítulos de libros sobre el tema "Optimisation de hit en lead"
Mazanetz, Michael, Richard Law y Mark Whittaker. "Hit and Lead Identification from Fragments". En De novo Molecular Design, 143–200. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2013. http://dx.doi.org/10.1002/9783527677016.ch6.
Texto completoDunlap, Norma y Donna M. Huryn. "Drug discovery: hit and lead identification". En Medicinal Chemistry, 19–50. New York, NY : Garland Science, Taylor & Francis Group, LLC, [2018]: Garland Science, 2018. http://dx.doi.org/10.1201/9781315100470-2.
Texto completoBraggio, Simone, Mauro Corsi, Aldo Feriani, Stefano Fontana, Luciana Marocchio y Caterina Virginio. "CHAPTER 15. Discovery Toxicology In Lead Optimisation". En The Handbook of Medicinal Chemistry, 364–412. Cambridge: Royal Society of Chemistry, 2015. http://dx.doi.org/10.1039/9781782621836-00364.
Texto completoCregan, Vincent y William T. Lee. "Optimisation of a Lead Sulphate Settling Process". En Trends in Mathematics, 1–6. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-030-01153-6_1.
Texto completoConnolly, Stephen y Simon E. Ward. "CHAPTER 21. Lead Optimisation: What You Should Know!" En The Handbook of Medicinal Chemistry, 529–65. Cambridge: Royal Society of Chemistry, 2015. http://dx.doi.org/10.1039/9781782621836-00529.
Texto completoKapoulitsas, P., M. Giunti, R. Hampson, A. Cranley, S. Gray, B. Kretschmer, R. Knight y J. Clark. "Commissioning and Optimisation of the New Lead and Silver Refinery at the Pasminco Port Pirie Smelter". En Lead-Zinc 2000, 187–202. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118805558.ch10.
Texto completoSewing, A. y D. Cawkill. "High-Throughput Lead Finding and Optimisation for GPCR Targets". En Ernst Schering Foundation Symposium Proceedings, 249–66. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/2789_2006_012.
Texto completoPignol, Jean-Philippe, Philippe Paquis, Roland Sabattier, Arlene Lennox, Thomas Kroc, Dan Jones, Jakobus Slabbert, Cheikh M. B. Diop, Gilbert Blondiau y Noël Breteau. "BNCEFN Optimisation with Lead Blocks Collimation and Graphite Embedding". En Frontiers in Neutron Capture Therapy, 741–46. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1285-1_107.
Texto completoHeifetz, Alexander, Michelle Southey, Inaki Morao, Andrea Townsend-Nicholson y Mike J. Bodkin. "Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery". En Methods in Molecular Biology, 375–94. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7465-8_19.
Texto completoLipinski, Christopher A. "Overview of Hit to Lead: The Medicinal Chemist's Role from HTS Retest to Lead Optimization Hand Off". En Topics in Medicinal Chemistry, 1–24. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/7355_2009_4.
Texto completoActas de conferencias sobre el tema "Optimisation de hit en lead"
Aimetta, A., N. Abrate, M. Massone y S. Dulla. "Advancements in the Genetic-Driven Optimisation of the Few-Group Structures for Lead Fast Reactors Analysis". En International Conference on Physics of Reactors (PHYSOR 2024), 1703–12. Illinois: American Nuclear Society, 2024. http://dx.doi.org/10.13182/physor24-43878.
Texto completoMo¨ller, Bjo¨rn Fredriksson, Mitsuru Obana, Mohsen Assadi y Athanasios Mitakakis. "Optimisation of HAT-Cycles – With and Without CO2 Capture". En ASME Turbo Expo 2004: Power for Land, Sea, and Air. ASMEDC, 2004. http://dx.doi.org/10.1115/gt2004-53734.
Texto completoPietrikova, Alena, L'ubomir Livovsky, Jan Urbancik y Radoslav Bucko. "Optimisation of Lead Free Solders Reflow Profile". En 2006 29th International Spring Seminar on Electronics Technology. IEEE, 2006. http://dx.doi.org/10.1109/isse.2006.365149.
Texto completo"Searching for bioactive drug lead compounds from natural humic substances". En Seventh International Conference on Humic Innovative Technologies "Humic substances and technologies for resilience" (HIT – 2022). NP CBR "Humus Sapiens", 2022. http://dx.doi.org/10.36291/hit.2022.071.
Texto completoAlexander, Brian G., Roberta Pireddu, Nan N. Sun, Huidong Yu, Kara D. Forinash, Matthew P. Martin, Ernst Schonbrunn, Wayne C. Guida, Said M. Sebti y Nicholas J. Lawrence. "Abstract 3243: Discovery of novel Rho kinase inhibitors: Hit generation and lead optimization". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3243.
Texto completoSeufitelli, Danilo Boechat y Mirella M. Moro. "Understanding Musical Success Beyond Hit Songs: Characterization and Analyses of Musical Careers". En Anais Estendidos do Simpósio Brasileiro de Sistemas Multimídia e Web, 23–24. Sociedade Brasileira de Computação - SBC, 2024. http://dx.doi.org/10.5753/webmedia_estendido.2024.244326.
Texto completoPireddu, Roberta, Harshani R. Lawrence, Mathew P. Martin, Stephane Betzi, Richard Yip, Hua Yang, Nan N. Sun et al. "Abstract 3253: Novel oxindole inhibitors of Aurora A kinase: Structure based hit-to-lead approach". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3253.
Texto completoKavicka, Frantisek, Josef Stetina, Karel Stransky, Jana Dobrovska, Bohumil Sekanina y Jaromir Heger. "A Numerical Model of Solidification of a Massive Casting From Malleable Cast-Iron". En ASME 2004 Heat Transfer/Fluids Engineering Summer Conference. ASMEDC, 2004. http://dx.doi.org/10.1115/ht-fed2004-56043.
Texto completoScherff, Maximilian L. D., Stefan Schwertheim, Yue Ma, Thomas Mueller y Wolfgang R. Fahrner. "10 × 10 cm2 Hit Solar Cells Contacted with Lead-Free Electrical Conductive Adhesives to Solar Cell Interconnectors". En Conference Record of the 2006 IEEE 4th World Conference on Photovoltaic Energy Conversion. IEEE, 2006. http://dx.doi.org/10.1109/wcpec.2006.279709.
Texto completoBaines, Olivia, Rina Sha, Christopher O’Shea y Davor Pavlovic. "BS10 Cardiac pacing location- optimisation of optical mapping protocols and pacemaker lead position". En British Cardiovascular Society Annual Conference, ‘Back to the patient’, 3–5 June 2024. BMJ Publishing Group Ltd and British Cardiovascular Society, 2024. http://dx.doi.org/10.1136/heartjnl-2024-bcs.236.
Texto completoInformes sobre el tema "Optimisation de hit en lead"
Chhoeung, Norinmony, Sesokunthideth Chrea y Nghia Nguyen. Cambodia’s Cash Transfer Program during COVID-19. Asian Development Bank Institute, diciembre de 2022. http://dx.doi.org/10.56506/rrmz8095.
Texto completoAmzallag, Robert. The return of inflation: a banker’s perspective. CIRANO, mayo de 2022. http://dx.doi.org/10.54932/egsn1582.
Texto completoOr, Etti, David Galbraith y Anne Fennell. Exploring mechanisms involved in grape bud dormancy: Large-scale analysis of expression reprogramming following controlled dormancy induction and dormancy release. United States Department of Agriculture, diciembre de 2002. http://dx.doi.org/10.32747/2002.7587232.bard.
Texto completo